URL: https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/016418s078lbl.pdf
%PDF-1.6
%����
73 0 obj
<>/OCGs[90 0 R]>>/Pages 66 0 R/Type/Catalog>>
endobj
74 0 obj
<>/Font<>>>/Fields[]>>
endobj
70 0 obj
<>stream
endstream
endobj
66 0 obj
<>
endobj
67 0 obj
<>
endobj
68 0 obj
<>
endobj
69 0 obj
<>
endobj
46 0 obj
<>/Font<>/ProcSet[/PDF/Text]/Properties<>/XObject<>>>/Rotate 0/StructParents 44/Type/Page>>
endobj
48 0 obj
<>/Font<>/ProcSet[/PDF/Text]/Properties<>/XObject<>>>/Rotate 0/StructParents 45/Type/Page>>
endobj
50 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>/XObject<>>>/Rotate 0/StructParents 46/Type/Page>>
endobj
57 0 obj
<>/Font<>/ProcSet[/PDF/Text]/Properties<>/XObject<>>>/Rotate 0/StructParents 47/Type/Page>>
endobj
59 0 obj
<>/Font<>/ProcSet[/PDF/Text]/Properties<>/XObject<>>>/Rotate 0/StructParents 48/Type/Page>>
endobj
107 0 obj
<>stream
q
1 0 0 1 -7.417969 3.242676 cm
0 0 612 792 re
W n
/Artifact <>BDC
q
1 0 0 1 7.417969 -3.242676 cm
BT
/OC /MC0 BDC
/GS0 gs
/TT0 1 Tf
12 0 0 12 64.582 748.2027 Tm
( )Tj
EMC
ET
Q
EMC
1 0 0 1 7.417969 -3.242676 cm
BT
/Span <>BDC
/GS0 gs
/TT1 1 Tf
-0.0014 Tc 0.0064 Tw 12 0 0 12 64.582 712.2027 Tm
[(INDE)-4 (RAL 60)]TJ
EMC
/P <>BDC
/TT0 1 Tf
0.0001 Tc -0.0001 Tw 5.86 0 Td
(\227Each hexagonal-shaped, pink, scored )Tj
0 Tc 0 Tw 16.11 0 Td
(tablet, em)Tj
12 0 0 12 134.902 712.2027 Tm
20.046 0 Td
(bossed with an \223I\224 and )Tj
0.0004 Tc -0.0004 Tw -25.906 -1.15 Td
[(im)8 (printed with \223INDERAL 60,\224 contains 60 m)8 (g )]TJ
0 Tc -0.001 Tw 19.55 0 Td
(propranolol hydrochloride, in bottles of 100 )Tj
0.0001 Tc -0.0001 Tw -19.55 -1.15 Td
(\(NDC 0046-0426-81\). )Tj
EMC
/Span <>BDC
/TT1 1 Tf
0 -2.16 TD
[(Store at con)6 (t)-2 (rolled room temperature 20\260 to 25\260 C \(68\260 to 77\260 F\); excur\
sions permitted to )]TJ
-0.0001 Tc -0.0006 Tw 0 -1.15 TD
(15\260 to 30\260 C \(59\260 to 86\260 F\). )Tj
EMC
/Span <>BDC
0.0001 Tc -0.0013 Tw 0 -2.15 TD
[(Dispense in a w)7 (e)-1 (ll-closed cont)]TJ
-0.0011 Tw 12.61 0 Td
(ainer as defined in the USP.)Tj
EMC
/P <>BDC
/TT0 1 Tf
0.005 Tc 0 Tw 11.83 0 Td
( )Tj
EMC
/Span <>BDC
/TT1 1 Tf
-0.0014 Tc 0.0064 Tw -24.44 -2.14 Td
[(INDE)-4 (RAL 80)]TJ
EMC
/P <>BDC
/TT0 1 Tf
0.0002 Tc -0.0002 Tw 5.86 0 Td
[(\227Each hexagonal-shaped, yellow, scored tablet, em)8 (bossed with an \223I\224 and )]TJ
0.0004 Tc -0.0004 Tw -5.86 -1.15 Td
(im)Tj
12 0 0 12 134.902 593.4027 Tm
-4.811 -1.15 Td
[(printed with \223INDERAL 80,\224 contains 80 m)8 (g )]TJ
0 Tc -0.001 Tw 18.501 0 Td
(propranolol hydrochloride, in bottles of 100 )Tj
0.0001 Tc -0.0001 Tw -19.55 -1.15 Td
(\(NDC 0046-0428-81\). )Tj
EMC
/Span <>BDC
/TT1 1 Tf
0 -2.16 TD
(Store at 20\260 to 25\260 C \(68\260 to 77\260 F\); excursions)Tj
0.0002 Tc -0.0002 Tw 19.71 0 Td
( permitted to 15\260 to 30\260 C \(59\260 to 86\260 F\). [See )Tj
0.0004 Tc -0.002 Tw -19.71 -1.15 Td
(USP Controlled Room Temperatu)Tj
12 0 0 12 64.582 539.8827 Tm
14.581 -1.15 Td
(re])Tj
EMC
/P <>BDC
/TT0 1 Tf
0 Tc 0 Tw 1.219 0 Td
( )Tj
EMC
/Span <>BDC
/TT1 1 Tf
0.0001 Tc -0.0013 Tw -15.8 -2.15 Td
[(Dispense in a w)7 (e)-1 (ll-closed cont)]TJ
-0.0011 Tw 12.61 0 Td
(ainer as defined in the USP. )Tj
EMC
/P <>BDC
/TT0 1 Tf
0.0004 Tc -12.61 -2.14 Td
(The appearance of these tablets is a regist)Tj
0.0007 Tc -0.0007 Tw 16.635 0 Td
(ered tradem)Tj
12 0 0 12 64.582 474.6027 Tm
21.381 0 Td
[(ark of Wyeth Pharm)9 (aceuticals.)6 ( )]TJ
EMC
/Span <>BDC
/TT1 1 Tf
0.001 Tc 0 Tw -21.381 -2.15 Td
(Wyeth)Tj
EMC
/Span <>BDC
/TT0 1 Tf
0 Tc 7.98 0 0 7.98 98.602 454.3227 Tm
(\256)Tj
EMC
/P <>BDC
12 0 0 12 104.662 448.8027 Tm
( )Tj
EMC
/P <>BDC
0.0008 Tc -0.0033 Tw -3.34 -2.15 Td
[(Wyeth Pharm)9 (aceuticals Inc. )]TJ
-0.0001 Tc 0.0017 Tw 0 -1.15 TD
(Philadelphia, PA 19101 )Tj
EMC
/P <>BDC
0.0003 Tc -0.0003 Tw 0 -2.15 TD
[(\(Update W)9 (1)-5 (0486C005\) )]TJ
0 -1.15 TD
(\(Update ET)Tj
12 0 0 12 64.582 383.4027 Tm
4.69 -1.15 Td
(01\) )Tj
0 Tc 0 Tw -4.69 -1.15 Td
(\(Update Rev Date\) )Tj
EMC
ET
/Artifact <>BDC
BT
/OC /MC0 BDC
12 0 0 12 64.582 42.0027 Tm
( )Tj
19 -0.005 Td
(18)Tj
EMC
ET
EMC
/Artifact <>BDC
Q
q
1 0 0 1 120.6970062 785.2004395 cm
/GS1 gs
/Fm0 Do
Q
EMC
/Artifact <>BDC
q
1 0 0 1 612 773.2004395 cm
/GS1 gs
/Fm1 Do
Q
EMC
endstream
endobj
109 0 obj
<>>>/Resources 113 0 R/Subtype/Form>>stream
0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts
BT
/ArialRoundedMTBold 10 Tf
0 0 1 rg
65.791 -7.9 Td
(This ) Tj
22.92 0 Td
(label ) Tj
26.055 0 Td
(may ) Tj
22.71 0 Td
(not ) Tj
18.12 0 Td
(be ) Tj
14.692 0 Td
(the ) Tj
18.023 0 Td
(latest ) Tj
29.595 0 Td
(approved ) Tj
48.974 0 Td
(by ) Tj
14.17 0 Td
(FDA. ) Tj
-281.05 -12 Td
(For ) Tj
18.96 0 Td
(current ) Tj
38.765 0 Td
(labeling ) Tj
41.055 0 Td
(information, ) Tj
61.25 0 Td
(please ) Tj
34.707 0 Td
(visit ) Tj
22.299 0 Td
(https://www.fda.gov/drugsatfda) Tj
ET
endstream
endobj
110 0 obj
<>>>/Resources 115 0 R/Subtype/Form>>stream
0 g 0 G 0 i 0 J []0 d 0 j 1 w 10 M 0 Tc 0 Tw 100 Tz 0 TL 0 Tr 0 Ts
BT
/ArialRoundedMTBold 10 Tf
0 0 1 rg
0 -7.9 Td
( ) Tj
ET
endstream
endobj
111 0 obj
<>
endobj
115 0 obj
<>
endobj
116 0 obj
<>
endobj
117 0 obj
<>
endobj
118 0 obj
<>
endobj
119 0 obj
<>stream
H��VyXG��9�P�@\�5r�@7���9�"�H�s4�:��� 3�����EE��j0��F"(E�ŬG��+o4[Qt]�c�o��m�W_�{�ޫ߫��� �P��@�-�{u�j��?�K��Rk�����$r�T� �, �)0=�Y4����X����j�T��bq�P�KS�O
2�q�XP�NHM������C��}&+�����*:G4:v ����-��:�C| ��x����Դ�u2�C`� �4G˲`@,{FCT-Uɕ5��״�4�6P�C\�:B[��d
�1�τ��ߌo���|���/b~��-R�# � Ra��������9�#�
�ם�`1 ��U���c��4; � @H�2@
Pа�76 }3 ˲��]�z�p�a���E�˵���{Kf���\������i���+� �V�Ps:���4ZM�5$h��1���C$��L$��4Z-���1�8��v{9��kT*B''�J4Q�JgKu�)S�T:����P���"�����'��
8�������G@�o{=o0���/D�z��A �q�K�lا��'"�G������d^��.�_l�[��u=�&�Zw�lw�mGv�=k��Ǟ�\l�%I��dSq��}��^\|��V4햦Mዜ_��ξ��i��6� ߙ�o �t�����?��6��qΓ&��G��T�T&�u��̹�;�)r��2uV�|�إ`S�N����7���x� Gֱ����)`Vף�����掎���ʺå׃
q�Z3xH�P=�ߺ��o��6��*hvjN��} 0 �H�1(���ʈu��N%�l�n�˚�ު�s5�I�4�����:
M$tY��@4����ݧơS�Câ�D�?DC��#�ő�E�菾9G? �1_� ��������7�������8���K_$z� rU�XY̸�ؕy���ۡ��f��z����y��J����Â�[뗏�yq�%57�� ��I]���ld=ʬ���%眓<ϵ��K��(��66��`����%#˕��1�Mskw���3v����a����ʗ�ǟ���lṽ������6������r�5Q�B���&y��٪*��ȗ�#�%��Le��;v]��e;w넬|v�"3����{�lcϛ�.�T&���nj.�v��-w[,]�U/c˞�TYظ
%�^�� W
